TY - JOUR
T1 - Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli
AU - Tatani, Solange Bernardes
AU - Fukujima, Márcia Maiumi
AU - Lima, João Augusto Costa
AU - Ferreira, Luiz Darcy Cortez
AU - Monaco Ghefter, Claudia G.
AU - Prado, Gilmar Fernandas
AU - Babayan, Zara
AU - De Azevedo, Lyamara Apostólico
PY - 2001
Y1 - 2001
N2 - Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.
AB - Objective - The purpose of this study is to evaluate the impact of transeophageal echocardiography on management of patients at low-risk for cardiogenic embolism to prevent new potential cardiovascular sources of emboli. Methods - We studied 69 patients with ischemia stroke at low-risk for cardiogenic embolism. Transeophageal echocardiography was performed to access: left atrium enlargement; communication or aneurysm of the interatrial septum; patent foramen ovale; spontaneous echo contrast or intracavitary thrombi; the presence of intraaortic atherosclerotic plaques or thrombi; significant valvar morphologic alteration or dysfunction; left ventricle enlargement, hypertrophy, or contractile abnormality. Transesophageal echocardiography altered clinical management, and we adopted anticoagulant therapy or another procedure apart from the use ofacetylsalicylic acid. Results - Transeophageal echocardiography detected at least one abnormality in 40 cases (58%). Clinical conduct was adjusted after the performance of transesophageal echocardiography in 11 patients (15.9%); anticoagulation was added in 10 cases and surgical correction in one patient. Conclusion - Transeophageal echocardiography was a very useful tool in the secondary prevention for stroke in patients at low risk for cardiogenic embolism.
KW - Embolism
KW - Stroke
KW - Transeophageal echocardiography
UR - http://www.scopus.com/inward/record.url?scp=0035379235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035379235&partnerID=8YFLogxK
U2 - 10.1590/S0066-782X2001000600003
DO - 10.1590/S0066-782X2001000600003
M3 - Article
C2 - 11449291
AN - SCOPUS:0035379235
SN - 0066-782X
VL - 76
SP - 458
EP - 461
JO - Arquivos brasileiros de cardiologia
JF - Arquivos brasileiros de cardiologia
IS - 6
ER -